SCHEMBL2809739

SCHEMBL2809739

O=C(O)CN(CCN1CC(=O)OC(=O)C1)CC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
EYA2 O00167 1/20 0.43
APP P05067 1/20 0.43
ACE P12821 1/20 0.43
BLM P54132 2/20 0.42
PMP22 Q01453 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2A P08913 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADRA1A P35348 1/20 0.42
DRD3 P35462 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL110199 0.97 TDP1 (0.48) TDP1EYA2APPACEBLM
SCHEMBL124918 0.97 TDP1 (0.42) TDP1EYA2APPACEBLM
SCHEMBL9152846 0.95 TDP1 (0.45) TDP1EYA2APPACEBLM
SCHEMBL19652368 0.92 TDP1 (0.37) TDP1EYA2APPACEBLM
SCHEMBL12438502 0.89 TDP1 (0.36) TDP1EYA2APPACEBLM
SCHEMBL15165746 0.89 TDP1 (0.33) TDP1EYA2APPACEBLM
SCHEMBL20143797 0.88 TDP1 (0.35) TDP1EYA2APPACEBLM
SCHEMBL14488349 0.88 TDP1 (0.39) TDP1EYA2APPACEBLM
SCHEMBL9715335 0.87 TDP1 (0.40) TDP1EYA2APPACEBLM
SCHEMBL13104003 0.87 TDP1 (0.48) TDP1EYA2APPACEBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120097-A1 POLYIMIDE ELECTROPHORETIC COATING, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 合肥汉之和新材料科技有限公司 2024-06-13 WO claimed
US-11945903-B2 Solventless compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2024-04-02 US claimed
US-11807705-B2 Solvent-based compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2023-11-07 US claimed
CN-115181263-A Branched polylysine macromolecular water reducing agent and preparation method and application thereof 广东红墙新材料股份有限公司 2022-10-14 CN claimed
US-20220275145-A1 SOLVENTLESS COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2022-09-01 US claimed
CN-113501886-B Cellulose nano-silver composite material and preparation method and application thereof 中南大学 2022-06-21 CN claimed
EP-3996917-A1 SOLVENTLESS COMPOSITIONS Dow Global Technologies LLC (US) 2022-05-18 EP claimed
EP-3997144-A1 WATER-BASED COMPOSITIONS Dow Global Technologies LLC (US) 2022-05-18 EP claimed
EP-3997151-A1 SOLVENT-BASED COMPOSITIONS Dow Global Technologies LLC (US) 2022-05-18 EP claimed
CN-113501886-A Anhydride esterification modified cellulose, cellulose nano-silver composite material, and preparation method and application thereof 中南大学 2021-10-15 CN claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
EP-2207525-A2 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT METHOD L'Oréal (FR) 2010-07-21 EP claimed
EP-2205201-A2 COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A POLYCONDENSATE, POLYCONDENSATE AND COSMETIC TREATMENT METHOD L'Oreal (FR) 2010-07-14 EP claimed
US-7605146-B2 Process for producing an amide compound NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) 2009-10-20 US claimed
WO-2009053594-A2 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2009-04-30 WO claimed
WO-2009053584-A2 COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A POLYCONDENSATE, POLYCONDENSATE AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2009-04-30 WO claimed
WO-2009053587-A2 COMPOSITION CONTAINING A POLYCONDENSATE, POLYCONDENSATE AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2009-04-30 WO claimed
EP-1199312-B1 Process for producing an amide compound SUMITOMO CHEMICAL CO (JP) 2004-07-21 EP claimed
EP-1199312-A2 Process for producing an amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 TDP1 3475/4885EYA2 1170/4885APP 3701/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA TDP1 3912/4885EYA2 3457/4885APP 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.